February 12, 2020 / 1:55 PM / 6 days ago

BRIEF-Vir Biotechnology Identifies Two Antibodies That Bind To The Spike Protein Of 2019-Ncov, Newly Named As Sars-Cov-2

Feb 12 (Reuters) - Vir Biotechnology Inc:

* VIR BIOTECHNOLOGY IDENTIFIES TWO ANTIBODIES THAT BIND TO THE SPIKE PROTEIN OF 2019-NCOV, NEWLY NAMED AS SARS-COV-2

* VIR BIOTECHNOLOGY INC - IDENTIFIED TWO MONOCLONAL ANTIBODIES THAT BIND TO SARS-COV-2

* VIR BIOTECHNOLOGY INC - ANTIBODIES TARGET SARS-COV-2 SPIKE PROTEIN IN REGION THAT VIRUS USES TO ENTER CELLS THROUGH CELLULAR RECEPTOR ACE2

* VIR BIOTECHNOLOGY INC - INVESTIGATING OTHER APPROACHES TO IDENTIFY ADDITIONAL POTENTIAL THERAPIES FOR SARS-COV-2

* VIR BIOTECHNOLOGY INC - EXPLORING ISOLATION OF NEW ANTIBODIES SPECIFIC FOR VIRUS USING ITS ANTIBODY TECHNOLOGY PLATFORM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below